FORMULARY DECISION
Folic acid + 5-Fluorouracil + Irinotecan + Oxaliplatin : FOLFIRINOX
For use in palliative chemotherapy for inoperable pancreatic adenocarcinoma in good performance status patients.
Search Results
All Content Formulary Only Other ContentWe have found 3 results when searching "Folic acid"
FORMULARY DECISION
Folic acid + 5-Fluorouracil + Irinotecan + Oxaliplatin : FOLFIRINOX
As adjuvant treatment following potentially curative resection of pancreatic cancer.
FORMULARY DECISION
Folic acid + 5-Fluorouracil + Oxaliplatin : FOLFOX
Second-line combination chemotherapy regimen for patients with pancreatic cancer who have progressed after first–line gemcitabine-based chemotherapy and are of very good performance status.